Immunotherapy drug for bladder cancer approved by FDA

Thursday, May 19, 2016 - 14:25 in Health & Medicine

Stephen FellerBETHESDA, Md., May 19 (UPI) -- The FDA approved the drug Tecentriq for bladder cancer, making another drug that shrinks or kills tumors by helping the immune system fight cancer cells.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net